Call - disappointing performance

Discussion in 'Acorda Therapeutics' started by anonymous, Oct 31, 2017 at 4:49 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Not a very impressive report card for the Quarter

    Not happy, dah.
     

  2. anonymous

    anonymous Guest

    You hanger ons better WAKE UP!
     
  3. anonymous

    anonymous Guest

    ***************************
    To the Original Poster:
    Attacking Leadership and disseminating questionable news does not benefit those of us working hard to grow the Company nor our investors. Implying on-going poor quarterly results and negative outlook is misleading and we might add insulting. Remember Rome was not built in a day ! We have a long-term plan that will generate rich rewards to our Team. We have brought in certified six sigma Black Belts to review all processes and morale issues. We are on track of continuing improvement towards nearly defect free execution.
    Please be more thoughtful in your posts.
    ***************************
     
  4. anonymous

    anonymous Guest

    Waiting in the lobby for our in-service program at 4pm. This is a big day as I'll have 4 major writers coming at the same time. Look the call isn't the field. My doctors want to write more, our job is to create the right incentives for growth. It's just following our training. Doctors want to be loved and cared for just like anyone else. Everybody likes an incentive. Got to go, in-service begins....
     
  5. anonymous

    anonymous Guest

    Some would call your Rah Rah campaign of deflection and avoidance questionable as well. Six sigma; process for the incompetent.
     
  6. anonymous

    anonymous Guest


    Correct! Rome was not built in a day but many years. ACOR is now falling apart after what? Over 20?? Please sire! Wake up and smell the incompetence! We will be sold. Heard companies are looking very closely.
     
  7. anonymous

    anonymous Guest


    Rome was at least built by people who knew how to build dude.
    PS: Everyone is looking given the blunders here. too easy a target.
    hello from a medical person thankful to be gone. I have no more stress or disbelief everyday
     
  8. anonymous

    anonymous Guest

    Well - if things are that bad - why did share price climbed to 28+ ???

    Ron must be doing something right
     
  9. anonymous

    anonymous Guest

    Two reasons

    1). The entire sector is up (thank you President Trump--who Ron opposed)

    2). Investors buying in anticipation of a continued bump when a sale occurs. It sure isn't due to increased revenue, pipeline news or a new NDA
     
  10. anonymous

    anonymous Guest

    market reaction says great call
     
  11. anonymous

    anonymous Guest

    Really?! It's down 3.37% for the day, not exactly a positive market reaction you tool.
     
  12. anonymous

    anonymous Guest

    Eh, Ron got an Award!!!

    That's great news for shareholders

    Who cares if the share price went down to 27 today.
     
  13. anonymous

    anonymous Guest

    was it a Halloween award for best impersonation of a Pharma CEO?
     
  14. anonymous

    anonymous Guest



    ...and THIS is FACT not FAKE NEWS!
     
  15. anonymous

    anonymous Guest

    *************************
    Our collective Leadership has always been recognized for its achievements. Remember, day to day valuation of ACOR is of no concern as the long term invester who looks at a12 month horizon (projected at $36 in year). Look for more awards as we fix the issues holding us back while recharging Leadership Team with new members. We cant loose. Go Go Go !!!!!!!
    *************************
     
  16. anonymous

    anonymous Guest

    WHY DON'T YOU JUS QUIT ??? WE DONT NEED LOOSERS LIKE YOU ! ! !